ICD leads: Design and chronic dysfunctions

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 2 I, 2003, Pages 649-657

  Gradaus, Rainer ^a   Breithardt, Günter ^a   Böcker, Dirk ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Implantable cardioverter defibrillator; Lead complications; Lead design; Lead failure; Leads

Indexed keywords

FLUORENE DERIVATIVE; POLYMER; POLYURETHAN; SILICONE;

CONDUCTOR; DEFIBRILLATOR; DEVICE REMOVAL; ELECTRODE; HEART VENTRICLE TACHYCARDIA; HUMAN; POSTOPERATIVE COMPLICATION; REVIEW; SURGICAL RISK; SURVIVAL;

EID: 0037306371     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00112.x     Document Type: Review

References (43)

1. Mirowski M, Mower MM, Staewen WS, et al. The development of the transvenous automatic defibrillator. Arch Intern Med 1972; 129:773-779.
2. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303:322-324.
3. Block M, Hammel D, Borggrefe M, et al. Erste klinische Erfahrungen mit einem transvenös-subkutanen Defibrillationssystem. Z Kardiol 1991; 80:657-664.
4. Wietholt D, Block M, Isbruch F, et al. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator. J Am Coll Cardiol 1993; 21:885-894.
5. Fromer M, Brachmann J, Block M, et al. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator: Results of a European multicenter study of 102 implants. Circulation 1992; 86:363-374.
6. Bardy GH, Troutman C, Poole JE, et al. Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device. Circulation 1992; 85:1689-1698.
7. Schaumann A, von zur Mühlen F, Herse B, et al. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. Circulation 1998; 97:66-74.
8. Bardy GH, Ivey TD, allen MD, et al. A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol 1989; 14:728-733.
9. Block M, Hammel D, Böcker D, et al. A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans. J Cardiovasc Electrophysiol 1994; 5:581-590.
10. Natale A, Sra J, Krum D, et al. Comparison of biphasic and monophasic pulses: Does the advantage of biphasic shocks depend on the waveshape? PACE 1995; 18:1354-1361.
11. Saksena S, An H, Mehra R, et al. Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol 1992; 70:304-310.
12. Block M, Breithardt G. Long-term follow-up and clinical results of implantable cardioverter-defibrillators. In DP Zipes, J Jalife, (eds.): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, WB Saunders Co., 1995, pp. 1412-1425.
13. Hammel D, Black M, Borggrefe M, et al. Implantation of a cardioverter/defibrillator in the subpectoral region combined with a nonthoracotomy lead system. PACE 1992; 15:367-368.
14. Block M, Hammel D, Böcker D, et al. Subpectoral implantation of ICD devices. PACE 1994; 17:800.
15. Nisam S, Kaye SA, Mower MM, et al. Subpectoral implantation of ICD generators: Long-term follow-up. PACE 1995; 18:159-162.
16. Thakur RK, Ip JH, Mehta D, et al. Subpectoral implantation of ICD generators: Long-term follow-up. PACE 1995; 18:159-182.
17. Lavergne T, Daubert JC, Chauvin M, et al. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 1997; 20:182-188.
18. Block M, Hammel D, Böcker D, et al. Present and future indications for therapy with implantable cardioverter defibrillators. In N El-Sherif, J Lekieffre, (eds.): Practical Management of Cardiac Arrhythmias. Armonk, NY, Futura Publishing Co., 1997; pp. 305-319.
19. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998; 31:1175-1209.
20. The Antiarrhythmics Versus Implantable Defibrillator (AVID) investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
21. Aram G. Product performance report 8/2000. Tachyarrhythmia products. Medtronic Inc., 7000 Central Avenue NW, Minneapolis, MN 55432-3576, USA.
22. Hauser RG, Cannom D, Hayes DL, et al. Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. PACE 2002; 25:879-992.
23. Peralta AO, John RM, Martin DT, et al. Long term performance of the Endotak C defibrillator lead. (abstract) Circulation 1998; 98:1-787.
24. Schwacke H. Drögemüller A, Siemon G, et al. Lead-related complications in 340 patients with an implantable cardioverter/defibrillator (in German) Z Kardiol 1999; 88:559-565.
25. Jones GK, Bardy GH, Kudenchuk PJ, Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: Implications for management and future system design. Am Heart J 1995; 130:327-333.
26. Schwartzman D, Nallamothu N, Callans DJ, et al. Postoperative lead-related complications in patients with nonthoracotomy defibrillator lead systems. J Am Coll Cardioln 1995; 26:776-786.
27. Grimm W, Menz J, Hoffmann J, et al. Complications of third-generation implantable cardioverter-defibrillator therapy. PACE 1999; 22:206-211.
28. Saksena S. Defibrillation threshold and perioperative mortality associated either endocardial and epicardial defibrillation lead systems. The PCD investigators and participating institutions. PACE 1993; 16:202-207.
29. Korte T, Jung W, Spehl S, et al. Incidence of ICD lead related complications during long-term follow-up: Comparison of epicardial and endocardial electrode systems. PACE 1995; 18:2053-2061.
30. Chevalier P, Mancada E, Canu G, et al. Symptomatic pericardial disease associated with patch electodes of automatic implantable cardioverter defibrillator: An underestimated complication? PACE 1996; 19:2150-2152.
31. Connolly SJ, Gent M, Roberts RS, et al., for the CIDS Investigators. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101:1297-1302.
32. Connolly SJ, Hallstrom AP, Cappato R, et al., on behalf of the investigators of the AVID. CASH, and CIDS studies. Meta-analysis of implantabie cardioverter defibrillator secondary prevention trials. Eur Heart J 2000; 21:2071-2078.
33. Camm AJ, Nisam S. The utilization of the implantable defibrillator - a European enigma. Eur Heart J 2000; 21:1998-2004.
34. DeCook CC, Vinkers M, Campe CMC, et al. Long-term outcome of patients with multiple (≥ 3) noninfected transvenous leads: A clinical and echocardiographic study. PACE 2000; 23:423-426.
35. Gradaus R, Lamp B, Hammel D, et al. Multiple hardware related complications in a patients with an ICD. Europace 1999; 1:270-274.
36. Alt E, Neuzner J, Binner L, et al. Three-year experience with a stylet for lead extraction: A multicenter study. PACE 1996; 19:18-25.
37. Epstein LM, Byrd CL, Wilkoff BL, et al. Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation 1999; 100:516-525.
38. Nägele H, Ismail M, Rödiger W. Excimer laser extraction of pacemaker and defibrillator leads. (in German) Z Kardiol 2001; 90:550-556.
39. Manolis AS, Maqunis TN, Vassilikos V, et al. Ancillary tools in pacemaker and defibrillator lead extraction using a novel lead removal system. PACE 2001; 24:282-287.
40. Wilkoff BL, Byrd CL, Love CJ, et al. Pacemaker lead extraction with the laser sheath: Results of the pacing lead extraction with the excimer sheath (Plexes) trial. J Am Coll Cardiol 1999; 33:1671-1676.
41. Le Franc P, Klug D, Jarwe M, et al. Extraction of endocardial implantable cardioverter-defibrillator leads. Am J Cardiol 1999; 84:187-191.
42. Bracke F, Meijer A, Van Gelder B. Extraction of pacemaker and implantable cardioverter defibrillator leads: Patient and lead characteristics in relation to the requirement of extraction tolls. PACE 2002; 25:1037-1040.
43. O. Tyers GF. Similar indications but different methods: Should there be a consensus on optimal lead extraction techniques? PACE 2002; 25:1019-1022.